South Korea
| ||||||||||||||||||||||||||||||||||||
Contents |
Key laws and policies
- Life Ethics Law (January 29, 2004)
- Bioethics and Biosafety Act (2005)
- Ministry of Health and Welfare, Guidelines on the Safety of Biotechnology Research (2000)
Prohibited practices
The following practices are prohibited:
- Sex selection
- Compensated as well as obtaining personal benefits (monetary or non-monetary) for the use of gametes
- Reproductive cloning
The Bioethics and Biosafety Act prohibits gene transfer of gametes, embryos, and fetuses. The Guidelines on the Safety of Biotechnology Research prohibit all inheritable genetic modification.
Permitted and regulated practices
The Bioethics and Biosafety Act limits tests on embryos to the treatment or prevention of disease.
The Life Ethics Law regulates embryonic stem cell research. According to the law, only supernumerary embryos produced for infertility treatments can be used for research. Thus, the creation of embryos for purposes other than infertility treatment is prohibited. However, the government will approve limited research on somatic cell nuclear transfer based on the guidelines drawn up by the National Ethics Committees.[1]
Surrogacy is unregulated.[2][3]
Accountability and governance
Human reproductive cloning is prohibited and subject to criminal sanctions for up to ten years in prison[4][5]
References
- ↑ http://www.glphr.org/genetic/asia2-07.htm
- ↑ Kirsty Horsey, "Surrogacy on offer between Japan and South Korea," BioNews (September 5, 2005)
- ↑ Korea's Surrogate Mother Industry Draws Japanese," Chosun Ilbo (October 17, 2006)
- ↑ “Biological Ethics Bill Passed by National Assembly,” Korean Ministry of Health and Welfare, Press Release (14 January 2004))
- ↑ http://www.glphr.org/genetic/asia2-07.htm
